Gossamer Bio GOSS 深 沪
已收盘 08-07 16:00:00 美东时间
0.178
0.000
-0.22%
华盛通- 最 高0.187
- 今 开0.18
- 成交量 1076.16万股
- 最 低 0.17
- 昨 收 0.1784
- 总市值 1.37万
- 52周最高 3.87
- 市盈率 静 --
- 换手率 13955.01%
- 52周最低 0.1138
- 委 比 95.64%
- 总股本 7.71万
- 历史最高 27.15
- 量 比 0.84
- 振 幅 9.53%
- 历史最低 0.1138
- 每 手 1
- 风险率 1.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate
Gossamer Bio plans a September 2026 NDA filing for seralutinib following FDA feedback and reacquires global rights.
07-28 02:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
Gossamer Bio Q1 EPS $(0.20) Misses $(0.13) Estimate, Sales $16.955M Beat $4.475M Estimate
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.13) by 53.85 percent. This is a 25 percent decrease over losses of $(0.16) per share from the
05-18 17:53
Cantor Fitzgerald Downgrades Gossamer Bio to Neutral
Cantor Fitzgerald analyst Olivia Brayer downgrades Gossamer Bio (NASDAQ:GOSS) from Overweight to Neutral.
03-23 17:56
These Analysts Slash Their Forecasts On Gossamer Bio
Gossamer Bio Inc. (NASDAQ:GOSS) on Monday shared topline results from the Phase...
02-24 22:34
Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings
U.S. stocks traded lower midway through trading, with the Dow Jones index dippi...
02-24 02:36
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price target.
2024-09-17 23:28
Gossamer Bio Announced Two Oral Presentations And Poster Presentation With Data Relevant To Seralutinib At European Respiratory Society Congress 2024
Gossamer Bio Announced Two Oral Presentations And Poster Presentation With Data Relevant To Seralutinib At European Respiratory Society Congress 2024
2024-08-27 04:02
